Robert Langor is listed as a director on 1 SEC Form D filing by 1 issuer in Mar 2010: Fibrocell Science, Inc. (Exton, PA — biotechnology — 2010; $45M reported sold to 114 investors).
What this means One deal on file with the SEC, filed Mar 2010. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside David Pernock (1 shared filing), Declan Daly (1 shared filing), Kelvin Moore (1 shared filing) and Paul Hopper (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Robert. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), state securities regulators (AZ, CA, DE, TX, WA) — none found. Not yet searched: SEC enforcement releases.
What this means Nothing turned up where we looked (2 sources). That does not prove there is nothing — it means none was found in those sources on that date.